Back to announcement
20241015_KLBF_Laporan Informasi dan Fakta Material_31746443_lamp2.pdf
Other Text extracted KLBFSource file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.892
5) ( KALBE No. Letter 5 070/CSEC-KF/X-2024 Jakarta, October 15, 2024 Attachment : - Stock code: KLBF Re t Disclosure of Information To: Indonesia Financial Services Authority Gedung Soemitro Djojohadikusumo Jl. Lapangan Banteng Timur No. 2 —4 Jakarta 10710 U.p.: Kepala Eksekutif Pengawas Pasar Modal Dear Sir / Madam, For and on behalf of the Company, hereby we disclose the following information or material facts: Name of Issuer or Public Company : PT Kalbe Farma Tbk (the “company”) Business fields : Processing industry, activities professional, scientific, technical and supporting business Telephone 4 021 -42873888 Facsimile 4 021 - 42873680 Email 4 maria.fabiola@kalbecorp.com corporate.secretary@kalbecorp.com 1. | Date of Event October 15, 2024 2. | Types of Material Information or | submission of information regarding Facts Development of the First Locally Produced CT Scan in Indonesia in Collaboration with GE Healthcare. This transaction is neither a Material Transaction nor a Conflict of Interest Transaction based on the Financial Services Authority (Otoritas — Jasa Keuangan) Regulation. | 3. | Description of Material | In compliance with Indonesia Financial Information or Facts Services Authority Regulation No. 31/POJK.04/2015 dated December 16, 2015, regarding Disclosure of Information or Material Facts by the Issuer or a Listed Company, The Company announced that through its subsidiary, PT Forsta Kalmedic Global (Forsta), partnered with GE HealthCare to locally provide CT Scan PT, KALBE FARMA Tbk. y f Head Office : Gedung KALBE, Jl. Let. Jend. Suprapto Kav. 4, Jakarta 10510, P.O. Box 3105 JAK, Jakarta, Indonesia. Tel. (021) 42873888 -89 Fax. (021) 42873680 Factory : Kawasan Industri Delta Silicon, Jl. M. H. Thamrin Blok A3 - 1, Lippo Cikarang, Bekasi 17550, P.O. Box 371 Bekasi 17037, Indonesia. Tel. (021)89907333 Fax. (021) 8972874 info@kalbe.co,id
Page 2 OCR 0.889
# KALSE (Computed Tomography Scan) machines. This partnership also expands the scope of collaboration between Kalbe and GE HealthCare, which have already been working | together in the development of radiopharmaceutical and radioisotope production facilities. 4. |The impact of the incident, | This collaboration is expected to enhance the information, or material factonthe | independence of using locally produced operational, law, financial | medical devices, a goal promoted by the condition, or business continuity of | government, and to advance healthcare the Issuer or Public Company services while supporting eguitable access to healthcare across Indonesia. It is also anticipated to strengthen the Companys Distribution and — Logistics Segment, particularly in the Medical Devices business. This is the information we can convey. We thank you for your attention and cooperation. Sincerely, Kalbe Farma Tbi ai Teresa Fabiola Corporate Secretary PT. KALBE FARMA Tbk. Head Office : Gedung KALBE, Jl. Let. Jend. Suprapto Kav. 4, Jakaria 10510, PO. Box 3105 JAK, Jakarta, Indonesia. Tel. (021) 42873888-89 Fax. (021) 42873680 Factory : Kawasan Industri Delta Silicon, Jl. M. H. Thamrin Blok A3 - 1, Lippo Cikarang, Bekasi 17550, P.O. Box 971 Bekasi 17037, Indonesia. Tel. (021)89907333 Fax. (021) 8972874 into@kalbe.co,id
Names mentioned 6 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Financial Services Authority
p.1 ×2
unresolved
org
PT Forsta Kalmedic Global
p.1
unresolved
person
H. Thamrin
p.1 ×2
unresolved
person
Teresa Fabiola
· Corporate Secretary
p.2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.